Cantor Fitzgerald’s Tiziana Life Sciences TLSA Stock Holding History

Cantor Fitzgerald’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,491	Closed	-$12.4K	–	535
2025 Q1	$12.4K	Hold	11,491	–	–	﹤0.01%	281
2024 Q4	$8K	Sell	11,491 -600	-5%	-$555	﹤0.01%	254
2024 Q3	$11.6K	Hold	12,091	–	–	﹤0.01%	190
2024 Q2	$11.1K	Hold	12,091	–	–	﹤0.01%	218
2024 Q1	$5.49K	Hold	12,091	–	–	﹤0.01%	242
2023 Q4	$6.77K	Hold	12,091	–	–	﹤0.01%	213
2023 Q3	$7.98K	Buy	+12,091	New	+$8.33K	﹤0.01%	518
2023 Q2	–	Sell	-25,491	Closed	-$27.8K	–	654
2023 Q1	$27.8K	Sell	25,491 -20,500	-45%	-$13.4K	﹤0.01%	599
2022 Q4	$28K	Hold	45,991	–	–	﹤0.01%	632
2022 Q3	$36K	Buy	+45,991	New	+$34.6K	﹤0.01%	666

Other funds holding TLSA

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Cantor Fitzgerald's TLSA Position: Q2 2025 in Review

Cantor Fitzgerald sold out of Tiziana Life Sciences (TLSA) in Q2 2025, closing a stake of 11,491 shares — an estimated $12.4K sold.

Cantor Fitzgerald first reported a position in TLSA in Q3 2022 and held it in 10 quarters. The position peaked at $36K in Q3 2022. 30 funds tracked by Wall St. Rank hold TLSA as of Q2 2025.

Cantor Fitzgerald reported no remaining Tiziana Life Sciences position as of Q2 2025 after selling out during the quarter.
Cantor Fitzgerald sold 11,491 Tiziana Life Sciences shares in Q2 2025, an estimated $12.4K.
Cantor Fitzgerald first reported a position in Tiziana Life Sciences in Q3 2022 and held it in 10 quarters.
Cantor Fitzgerald's Tiziana Life Sciences position peaked at $36K in Q3 2022.
30 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2025.

Based on Cantor Fitzgerald's 13F filing for Q2 2025, filed 14 Aug 2025.